Routine Ankle-Brachial Index (ABI) measurement: a window into atherosclerosis and early left ventricular dysfunction in patients diagnosed with cancer
We report, for the first time to our knowledge, the routine use of ABI testing among patients diagnosed with cancer. ABI showed a significant correlation to LV GLS, implying a potential tool in the early diagnosis of atherosclerosis and cardiotoxicity. Considering its low cost and availability, future prospective trials are needed to integrate its role in routine assessment.
Authors
- Yan Topilsky (ORCID: https://orcid.org/0000-0002-6101-8242)
- Michal Laufer‐Perl (ORCID: https://orcid.org/0000-0001-9105-2559)
- Shafik Khoury (ORCID: https://orcid.org/0000-0001-5190-9407)
- Ofer Havakuk
- Rafael Y. Brzezinski (ORCID: https://orcid.org/0000-0002-0172-2852)
- Shmuel Banai (ORCID: https://orcid.org/0000-0002-3299-2839)
- Moaad Slieman
- Netanel Golan
Institutions
- Tel Aviv University (IL)
- Hebrew University of Jerusalem (IL)
- Tel Aviv Sourasky Medical Center (IL)
- Weizmann Institute of Science (IL)
Publication Details
- Journal
- Cardio-Oncology
- Published
- 2024-09-12
- DOI
- https://doi.org/10.1186/s40959-024-00262-w
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Hebrew University of Jerusalem